您的位置: 首页 > 农业专利 > 详情页

FORMULAÇÃO E PROCESSO DE COMPRESSÃO DIRETA
专利权人:
NOVARTIS AG
发明人:
JAMES KOWALSKI,JAY PARTHIBAN LAKSHMAN,ARUN P. PATEL
申请号:
PT15199440
公开号:
PT3023095T
申请日:
2005.01.17
申请国别(地区):
PT
年份:
2018
代理人:
摘要:
Dipeptidylpeptidase IV inhibitor (herein referred to as DPP-IV) that may be 98.5-100% pure is a high-dose drug capable of being directly compressed with specific excipients into sold form dosage forms, such as tablets and capsules having desired, hardness, disintegrating ability and acceptable dissolution characteristics. DPP-IV is not inherently compressible and thus presents formulation problems. Excipients used in the formulation enhance the flow and compaction properties of the drug and tableting mix. Optimal flow contributes to uniform die fill and weight control. The binder used ensures sufficient cohesive properties that allow DPP-IV to be compressed using the direct compression method. The tablets produced provide an acceptable in vitro dissolution profile.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充